Bugs From Around the World

Much of the bacteria found in the oceans the world over can also be dredged up in the English Channel — about a third to two thirds of the bacterial taxa that are found at ocean sites around the world can be found there, researchers led by University of Chicago's Jack Gilbert report in the Proceedings of the National Academy of Science.

"It's an unprecedented overlap," Gilbert tells Ed Yong at Not Exactly Rocket Science.

The researchers performed deep sequencing of a sample obtained from a site in the western English Channel and compared their results to the 56 datasets that comprise the global International Census of Marine Microbes. Their results showing overlap between the channel and other ocean sites indicates that there may be "a previously undetected, persistent microbial seed bank," the researchers write in PNAS.

Yong notes that microbes can easily float around the world on ocean currents or the wind or be transported by animals. "Any bit of water in the oceans can be anywhere else once every 10,000 years," Gilbert tells him, "and these bugs have lived for 3 billion years."

Donald Glaser Dies

Donald Glaser, who won the Nobel Prize in physics before focusing on biological questions, has died, the New York Times reports. He was 86. Glaser built a bubble chamber that could be used to study subatomic particles, despite Enrico Fermi saying that such a chamber was impossible.

Glaser later turned to studying biology as he was "frustrated that particle physics was adopting huge atom smashers requiring large teams of scientists," the Times notes. He went on to found a biotechnology company called the Cetus Corporation that made the cancer therapies interleukin-2 and interferon. Cetus was then sold to Chiron Corporation, which was, in turn, acquired by Novartis.

Trove of Treasures

A virtual museum and library of the history of the science of modern genetics, including the original papers, notes, correspondences, photographs, and ephemera of Francis Crick, James Watson, Fred Sanger, Rosalind Franklin, and others is now open online, courtesy of the Wellcome Trust.

The Wellcome Library's Codebreakers website offers free access to the digitized papers that led to a mid-century explosion in the life sciences as well as a wide range of supporting materials such as a history of genetics from Darwin's time to today.

The Francis Crick archive includes extensive correspondences, scientific notes, lab notebooks, writings in draft, and papers from more than 50 years that trace the rise of molecular biology, including the earliest sketches of the double helix. Sanger's lab notes offer details into his research into the earliest development of DNA sequencing tools. Rosalind Franklin's scientific notes and papers are available, as are posthumous materials and her X-ray diffraction 'photo 51' picture of DNA.

The archive also includes papers from numerous other biologists and more than 650 digitized books on the history and social aspects of the genetics revolutions, and another half million pages will be added to Codebreakers over the next six months.

The project is the first phase of an effort that will eventually include integrated online content, films, more photographs, and audio covering the wide history of medicine and biomedical science.

The digitization project has cost £3.9 million ($5.9 million) so far, and another £5.8 million has been set aside to continue digitizing Wellcome Library's other holdings.

"Codebreakers reveals the extraordinarily convoluted networks of influence, insight and inspiration that lie behind crucial moments of scientific discovery. It is a project made possible by a creative partnership with five outstanding libraries and archives, sharing a goal of free and open access. Together, our collections offer an extraordinarily rich research resource documenting one of the most significant periods of scientific innovation in human history," says Wellcome Library head Simon Chaplin in a statement

The archive is a collaboration between Wellcome Trust, Cold Spring Harbor Laboratory, Churchill Archives Centre Cambridge University, the University of Glasglow, King's College London, and University College London, and includes papers and materials from all of these partners.

This Week in PNAS

In the early, online edition of the Proceedings of the National Academy of Sciences, Uppsala University's Ulf Gyllensten and colleagues describe genetic variants that appear to affect peptide levels in the human blood proteome. The team assessed SNP patterns in more than 1,000 Swedish individuals, while using mass spectrometry to characterize and quantify peptides in their blood. The genome-wide association study led to apparent "protein quantitative trait loci," or pQTLs, for 60 peptides representing just over twodozen proteins. Those involve argue that the potential for using high-throughput proteomic and genomic schemes to assess genetic influences on the proteome "opens up the possibility for systemic studies of the functional importance of specific genetic variants on the protein."

Our sister publication GenomeWeb Daily News has more on the study, here.

A trio of researchers from the University of Georgia takes a peek at gene function in the methanogenic archaeal species Methanococcus maripaludis using transposon-mediated mutagenesis and deep sequencing. The team mapped transposon insertion sites in the M. maripaludis genome in mutant lines, using this information to gain clues about whether various genes are essential or beneficial for the bug's growth under given conditions. "Although definitive assignments of essentiality still require detailed analyses of each gene, the methodology generates hypotheses about the nature of specific genes and a great deal of insight into specific questions regarding methanogens," study authors say, "as well as more general questions about the genetics, biochemistry, and physiology of archaea."

Members of the Alzheimer's Disease Neuroimaging Initiative and collaborators report on findings from a modified GWAS designed to pin down variants contributing to brain connectivity. The group started by doing brain scans on dozens of identical or non-identical twin pairs as a means of teasing apart heritable aspects of brain networks. Using this information, together with genotyping data, researchers unearthed variants with apparent ties to brain connectivity. Among them: a SNP near the SPON1 gene that appeared to influence brain structure and dementia risk in follow-up analyses. From these and other findings, study authors concluded that the connectome/genome-wide screening approach "offers substantial promise to discover genes affecting brain connectivity and risk for brain diseases."

Caught in the Circle

Circular non-coding RNA can bind and block microRNAs, affecting gene expression, according to two studies appearing in the online early version of Nature last week.

"There seems to be a whole new layer of gene regulation," Jørgen Kjems from Aarhus University in Denmark tells LiveScience.

In their paper, Kjems and his Aarhus University colleagues report that a circular RNA found in human and mouse brains binds and holds on to miR-7. This, they add, leads to increased activity of the genes miR-7 usually targets for suppression. Another circRNA, found in the testis, targets a separate microRNA, miR-138, suggesting to the researchers that these "sponge" effects of circular RNA "are a general phenomenon."

Indeed, a separate group of investigators at Max-Delbrück-Center for Molecular Medicine reports similar findings. They report finding a number of stable circRNAs that are commonly expressed in certain tissues or at particular developmental stages. Further, they show in zebrafish that changes to the circRNA or to miR-7 affect brain development. This, they add, provide evidence that circRNA act as post-transcriptional regulators.

"It's yet another terrific example of an important RNA that has flown under the radar," notes Erik Sontheimer from Northwestern University in a Nature News piece. "You just wonder when these surprises are going to stop."

Jane Wright Dies

Jane Wright, an oncologist who was among the founders of the American Society of Clinical Oncology, has died, reports the New York Times. She was 93. After attending New York Medical College, Wright joined her father Louis Wright, who was one of the first black graduates of Harvard Medical School, at Harlem Hospital, working at a cancer research center there. They studied the effects of new chemotherapeutic agents on mice with leukemia and, later, in patients.

In 1964, Wright joined with six other physicians to found ASCO. She also served on Lyndon Johnson's President's Commission on Heart Disease, Cancer, and Stroke.

"Not only was her work scientific, but it was visionary for the whole science of oncology," Sandra Swain, the current ASCO president, tells the Times. "She was part of the group that first realized we needed a separate organization to deal with the providers who care for cancer patients. But beyond that, it's amazing to me that a black woman, in her day and age, was able to do what she did."

In the DNA Depths

After getting her exome sequenced, IEEE Spectrum's Eliza Strickland is at first a bit disappointed but then changes her mind. Going through Ion Torrent's Jonathan Rothberg and James Lupski at Baylor Medical College, Strickland decides to have her exome sequenced and have medically actionable results returned to her. "I hope I'll get early warnings about problems I may encounter later in life and suggestions on screening regimens or lifestyle changes that can protect me," she writes.

Strickland learned that she did have some genes linked to "scary words" like Parkinson's disease and kidney failure, but the Baylor doctors assured her that she had nothing to currently worry about. She also learned she was a carrier for Usher's syndrome, which is linked to deafness. "The crystal ball has turned up a lot of possibilities, and a few shadowy grim reapers are waving from the murky depths," she writes. "But the results probably won’t change my life in any meaningful way."

But then, Strickland does a little bit more digging and finds that Usher's syndrome is associated not only with deafness, but with night blindness and balance problems — issues that her mother and uncle have had. Her mother, she says, could be further tested and monitored.

When Strickland relates her mild disappointment that she didn't find out much that would lead her to make changes to her lifestyle, Rothberg he tells her that that's the curse of being one of the first. "We're at a tipping point," he adds, "and we're just starting to sequence individuals. So we don't have a lot of information that correlates your sequence with outcome. Right now there's only a handful of genes that we can tell you something about."

This Week in PLOS

University of Florida researchers looked at genetic variation in lice in the context of louse ecotype and the infected human population in a PLOS One study. Investigators turned to genomic analyses to find 15 louse microsatellite markers that they subsequently used to genotype head and clothing lice from nearly 100 individuals in North America, Central America, Asia, and Europe. Lice genetic profiles differed between clothing and head louse ecotypes, researchers report, and between lice from one geographical site and the next. As such, those involved in the study say microsatellite markers in lice may be useful for understanding not only louse biology and infection patterns, but also human migration history. For more on this study, see our sister publication GenomeWeb Daily News.

Mice exposed to ionizing radiation such as X-rays or gamma-rays show a shift in their blood microRNA profiles, according to another study in PLOS One. Using a digital, hybridization-based assay, researchers from Ohio State University and elsewhere tested blood samples from mice exposed to individual doses of gamma radiation or multiple X-ray treatments. Compared to untreated or sham-treated control animals, blood samples from the radiation-exposed mice exhibited a boost or dip in the expression of many miRNAs. At least a few of these miRNA expression changes seemed to coincide with radiation dose or related damage, the team notes, suggesting human versions of some of the miRNAs might eventually prove useful for tracking an individual's radiation exposure and/or risk of related complications. GWDN has more on the study here.

In PLOS Genetics, an international research team genotyped more than 1,300 Lebanese individuals as part of its effort to more clearly define historical human migrations in a Near East area known as the Levant. When they compared SNP profiles in the Lebanese samples with those found in individuals from four dozen other populations around the world, the investigators detected genetic patterns that appear to reflect ancient and more recent historical events in the Levantine. For example, results from the analysis suggest that Levantine populations tended to be more genetically related to Europeans prior to Islamic expansion into the region. On the other hand, some populations in the area now cluster more closely with populations in the Middle East and Africa — a pattern that the study's authors attribute to admixture between individuals with shared cultural and religious affiliations.

Am Scientist, Would Like to Travel

As part of an initiative to cut costs and in the wake of scandal surrounding a lavish conference, the Obama administration has moved to limit spending on travel by government employees. But Representative Rush Holt (D-New Jersey) told the Committee on Oversight and Government Reform, which convened a hearing to evaluate the travel restrictions, that scientists need to be able to attend conferences, ScienceInsider reports. Holt is a trained physicist.

"As a scientist, I know firsthand how important scientific conferences and meetings are," Holt's written testimony to the committee said. "The informal conversations, as well as the formal presentations and poster sessions that go into a conference among scientists from different institutions lead to new collaborations that have the promise of new discoveries. These are not fancy junkets."

ScienceInsider notes that the Department of Health and Human Services, spent $56.1 million on 140 conferences during fiscal year 2012.

Shared Risk

A genome-wide SNP analysis found that five mental disorders share four risk loci. The researchers from the Cross-Disorder Group of the Psychiatric Genomics Consortium report in The Lancet that two of the four loci could be traced to genes encoding two subunits, CACNA1C and CACNB2, of L-type voltage-gated calcium channels.

The researchers examined the genomes of 33,332 people with attention deficit hyperactivity disorder, autism, bipolar disorder, major depression, or schizophrenia, and 27,888 controls, all with European ancestry. From this, they found those four risk loci. Pathway analysis, they add, indicates that the calcium channel signaling gene may play a role in each of the disorders.

Jordan Smoller, a member of the consortium and an author on the paper, tells the New York Times that "the calcium channel findings suggest that perhaps — and this is a big if — treatments to affect calcium channel functioning might have effects across a range of disorders."

In a related comment in The Lancet, Alessandro Serrettia and Chiara Fabbria from the University of Bologna note that these finding bolster previous evidence of pleiotropy in complex disorders.

They add that "the present study might contribute to future [disease description] systems, which could be based not only on statistically determined clinical categories, but also on biological pathogenic factors that are pivotal to the identification of suitable treatments."

Big Data Training

The US National Institutes of Health is seeking comments for its the Big Data to Knowledge initiative, Sally Rockey, the deputy director for extramural research at NIH, writes at her Rock Talk blog. The BD2K initiative, she says, aims to find effective ways to use and manage the large datasets coming out of new biomedical studies.

One part of the initiative is to focus on honing the skills of researchers so that they can work with such data, and that, Rockey says, is what NIH wants to hear about. "NIH asks for your input on both the short and long-term training needs of individuals who work with biomedical data, seeks examples of programs or strategies to cross-train scientists at all career levels, and also requests comments on evaluating workforce skills and knowledge and developing a diverse research workforce," she writes.

The comment period ends March 15.

This Week in Science

In Science this week, a multi-institute team of Australian researchers reports on the discovery of a protein found in the female reproductive tract that appears to protect against sexually transmitted diseases. The protein, interferon-epsilon, is expressed by cells that line the ovary, uterus, cervix, and vagina, and mice lacking interferon-epsilon are more susceptible to infection with herpes simplex virus 2 and chlamydia. The regulatory and protective properties of interferon-epsilone may "facilitate the development of new strategies for preventing and treating STIs and, perhaps, other diseases," the researchers say.

Also in Science, a group of Japanese and Australian researchers provide evidence that a family of genes called KNOX2 may be behind the haploid-to-diploid morphological transition found in land plants. "In mosses, the haploid gametophyte generation is dominant, whereas in vascular plants — including ferns, gymnosperms, and angiosperms — the diploid sporophyte generation is dominant," the researchers note. In their study, the scientists found that KNOX2 genes appear to suppress the development of a normal reproductive form of moss during its spore-producing generation, "indicating a critical role for the evolution of KNOX2 in establishing an alternation of generations in land plants."

All Sequester's Eve

The showdown in Washington, DC, over the sequester is unlikely to be resolved before the March 1 deadline, Politico reports, predicting that bills aimed at preventing the across-the-board cuts are merely "political cover" and will fail to receive the required number of votes to pass the US Senate.

Funding agencies and research institutes across the US are already planning for dealing with funding cuts.

The National Institutes of Health, the Huffington Post reports, has already scaled back some grants by 10 percent in anticipation of the sequester. The National Science Foundation has said, according to ScienceInsider, that its existing grants won't be affected by sequestration, but the number of new grants that it will fund would drop by about 1,000. If the sequester goes into place, the NIH and NSF budgets both face about a 5 percent cut.

Biomedical research labs rely heavily on federal funding to keep their research programs going. Keith Yamamoto, vice chancellor for research at the University of California, San Francisco, notes that salaries and stipends are the biggest costs for most labs. "There's just no way to escape the impact on employment," he tells HuffPo. Scott Zeger, the vice provost for research at Johns Hopkins University, similarly says that labs would have to become smaller under sequestration cuts.

The Harvard Crimson reports that some labs there have sought to contain costs by cutting staff and spending less on equipment and reagents.

The effect, Marc Kastner, a the dean of the School of Science at MIT, tells Tom Levenson at Scientific American's Guest Blog, will be felt most acutely by smaller labs and by graduate students, postdocs, and people who are supported by soft money. "Is ever Eric Lander going to slow down? He'll find a way," Kastner says, adding that "the rich survive and the poor get devastated. The real question is the next generation."

Research will, of course, continue on, but Zeger tells the Huffington Post that the pace will slow. "America will be a little bit less competitive. We're still going to make these discoveries ultimately. It may take a little longer, people may suffer in the meantime, but we're going to make these discoveries. It's human nature," Zeger says to HuffPo. "The question is, what role does America want to play in the discoveries that will define our future?"